See more : Salama Cooperative Insurance Company (8050.SR) Income Statement Analysis – Financial Results
Complete financial analysis of Branded Legacy Inc (BLEG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Branded Legacy Inc, a leading company in the Packaged Foods industry within the Consumer Defensive sector.
You may be interested
- Stora Enso Oyj (STEAV.HE) Income Statement Analysis – Financial Results
- Thonburi Healthcare Group Public Company Limited (THG.BK) Income Statement Analysis – Financial Results
- Green World Fintech Service Co., Ltd. (6763.TWO) Income Statement Analysis – Financial Results
- GHCL Limited (GHCL.NS) Income Statement Analysis – Financial Results
- Nordson Corporation (NDSN) Income Statement Analysis – Financial Results
Branded Legacy Inc (BLEG)
About Branded Legacy Inc
Branded Legacy Inc engages in the commercial development of hemp and cannabinoid-infused beverages in Central Florida. It provides CBD topicals and tinctures, and hemp coffees and teas. The company was formerly known as Elev8 Brands, Inc. and changed its name to Branded Legacy Inc in May 2020. Branded Legacy Inc is headquartered in Longwood, Florida.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 82.91K | 215.53K | 64.26K | 100.63K | 604.50K | 372.31K | 144.76K | 191.00 | 16.90K |
| Cost of Revenue | 265.00 | 72.62K | 33.19K | 77.98K | 236.61K | 159.46K | 69.29K | 0.00 | 8.24K |
| Gross Profit | 82.64K | 142.91K | 31.07K | 22.65K | 367.89K | 212.84K | 75.47K | 191.00 | 8.66K |
| Gross Profit Ratio | 99.68% | 66.31% | 48.35% | 22.51% | 60.86% | 57.17% | 52.14% | 100.00% | 51.25% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 252.29K | 244.12K | 682.19K | 477.53K | 158.24K | 364.00 | 76.48K |
| Selling & Marketing | 0.00 | 0.00 | 92.59K | 76.99K | 136.74K | 103.13K | 42.70K | 0.00 | 0.00 |
| SG&A | -3.74M | 306.61K | 344.87K | 321.11K | 818.92K | 580.66K | 200.93K | 364.00 | 76.48K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -30.00 | -171.00 |
| Operating Expenses | -3.74M | 306.61K | 344.87K | 321.11K | 818.92K | 580.66K | 200.93K | 364.00 | 76.48K |
| Cost & Expenses | -3.74M | 379.23K | 378.06K | 399.09K | 1.06M | 740.12K | 270.22K | 364.00 | 84.72K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 42.00 | 0.00 |
| Depreciation & Amortization | 167.90K | 20.63K | 236.56K | 3.61K | 3.59K | 3.54K | 52.52K | 22.82K | 250.00 |
| EBITDA | 3.83M | -143.07K | -313.80K | -294.85K | -2.05M | -364.27K | -125.46K | -173.00 | -67.57K |
| EBITDA Ratio | 4,614.24% | -66.39% | -488.37% | -293.01% | -74.61% | -97.84% | -86.67% | -90.58% | -399.80% |
| Operating Income | 3.83M | -163.70K | -313.80K | -298.46K | -451.03K | -367.82K | -125.46K | -173.00 | -67.82K |
| Operating Income Ratio | 4,614.24% | -75.95% | -488.37% | -296.61% | -74.61% | -98.79% | -86.67% | -90.58% | -401.28% |
| Total Other Income/Expenses | 0.00 | -1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -72.00 | -369.00 |
| Income Before Tax | 3.83M | -163.70K | -313.80K | -298.46K | -451.03K | -367.82K | -125.46K | -245.00 | -68.19K |
| Income Before Tax Ratio | 4,614.24% | -75.95% | -488.37% | -296.61% | -74.61% | -98.79% | -86.67% | -128.27% | -403.47% |
| Income Tax Expense | -167.90K | -5.00 | -236.56K | -1.00 | -1.61M | -157.60K | -52.52K | -22.77K | 198.00 |
| Net Income | 3.83M | -163.70K | -313.80K | -298.46K | -451.03K | -367.82K | -125.46K | -245.00 | -68.19K |
| Net Income Ratio | 4,614.24% | -75.95% | -488.37% | -296.61% | -74.61% | -98.79% | -86.67% | -128.27% | -403.47% |
| EPS | 0.01 | 0.00 | -0.17 | -0.01 | -0.24 | -0.26 | -0.07 | 0.00 | 0.00 |
| EPS Diluted | 0.01 | 0.00 | -0.17 | -0.01 | -0.24 | -0.25 | -0.07 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 295.00M | 227.85M | 1.90M | 50.14M | 1.90M | 1.44M | 1.93M | 2.29M | 0.00 |
| Weighted Avg Shares Out (Dil) | 295.00M | 227.85M | 1.90M | 50.14M | 1.90M | 1.48M | 1.93M | 2.29M | 0.00 |
Branded Legacy, Inc. Expands Operations with Move to State of the Art Biotech Facility in Melbourne, FL
White Label Deal Secured, 1,700,000 Preferred Series Shares Repurchased and Retired MELBOURNE, Fla. , Feb. 8, 2024 /PRNewswire/ -- (OTC-PK: BLEG), a prominent Biotech company, proudly announces a significant leap forward in its growth journey with the acquisition of a...
Branded Legacy, Inc. Innovates with Launch of the First 100% Clear Kava-Based Vaping Product on the Market
Three New Products Released Today, With Six More on the Horizon MELBOURNE, Fla. , Feb. 6, 2024 /PRNewswire/ -- Branded Legacy, Inc. (OTC.PK: BLEG), a prominent Biotech company, proudly announces a major breakthrough in research and development efforts, leading the...
Branded Legacy, Inc. Unveils Major Equipment Acquisition Raising Total Assets to $3,787,215.00
Asset Portfolio Increases By 1,412% In Under 2 Months MELBOURNE, Fla. , Jan. 30, 2024 /PRNewswire/ -- Branded Legacy, Inc. (OTC.PK: BLEG), a leading innovator in research, development, and production, announces that it has increased its assets to $3,787,215.00, which is...
Branded Legacy, Inc. Reduces Debt by 1.5 Million
Branded Legacy, Inc. (OTC.PK: BLEG) Takes Bold Step in Financial Management: Eliminates $1.5 Million in Debt and Safeguards Against Conversions MELBOURNE, Fla. , Jan. 25, 2024 /PRNewswire/ -- Branded Legacy, Inc., a leading Biotech company, proudly announces a significant milestone...
Branded Legacy, Inc. ($BLEG) Announces Reduction in Authorized Share Count to 900M
In a strategic move to align with its capital structure and business objectives, Branded Legacy, Inc. reduces its authorized share count by 600 million. MELBOURNE, Fla.
Branded Legacy, INC Successfully Closes Acquisition of All In Extracts, LLC
In a Move That Showcases the Power of Cooperation Over Competition, Companies Join Forces to Bring Exciting New Products to Market In a Move That Showcases the Power of Cooperation Over Competition, Companies Join Forces to Bring Exciting New Products...
Branded Legacy, Inc. ($BLEG) Retires Additional 442 Million Common Shares, Surpassing Initial Commitment
MELBOURNE, Fla., Jan. 02, 2024 (GLOBE NEWSWIRE) -- via IBN — Branded Legacy (OTC: BLEG) is further highlighting its commitment to shareholders and future growth by announcing the final retirement of an additional 442 million common shares, bringing the total...
Branded Legacy, Inc. (BLEG) Announces Retirement of 400,000,000 Common Shares, Achieving Target of 2 Billion in Share Reductions with More to Come
Company closes strategic purchase of ultra-efficient analytical equipment, supporting sustainability initiatives Company closes strategic purchase of ultra-efficient analytical equipment, supporting sustainability initiatives
Branded Legacy, Inc. (BLEG) Expands Portfolio with Comprehensive Acquisition of MariJ Pharmaceuticals Inc, Including Licenses, Organic Certifications, and Substantial Assets
Acquisition marks the largest acquisition to date with multi-state processing licenses, compounding pharmacy license, and advanced equipment Acquisition marks the largest acquisition to date with multi-state processing licenses, compounding pharmacy license, and advanced equipment
Branded Legacy Commences Buyback of 1,000,000 Preferred Class D Shares
Strategic Plan to Prevent Conversion into 100 Million Common Unrestricted Shares, Enhancing Shareholder Value Strategic Plan to Prevent Conversion into 100 Million Common Unrestricted Shares, Enhancing Shareholder Value
Source: https://incomestatements.info
Category: Stock Reports